We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
USA - March 21 2012
On March 20, 2012, the United States Supreme Court issued a unanimous decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc., holding the claimed diagnostic methods ineligible for patent protection under Section 101 of the Patent Act.
